In summary, IPA suggests that c-Abl inhibition via Ponatinib has a significant rescuing effect on gene expression patterns and pathways disrupted by rotenone and H. pylori in SH-SY5Y cells, including those related to neuroinflammation and PD-related pathways. The gene discussed is ABL1; the disease is Parkinson disease.